Viberzi FDA Approval History
FDA Approved: Yes (First approved May 27, 2015)
Brand name: Viberzi
Generic name: eluxadoline
Dosage form: Tablets
Company: Allergan plc
Treatment for: Irritable Bowel Syndrome
Viberzi (eluxadoline) is a mu-opioid receptor agonist indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.
Development timeline for Viberzi
| Date | Article |
|---|---|
| May 27, 2015 | Approval FDA Approves Viberzi (eluxadoline) for Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults |
| Sep 2, 2014 | Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
